Team
A founding team that brings together the management of complex skin cancers, laboratory science, and direct access to the patients that need this new therapy.
Consultant dermatologist and Mohs micrographic surgeon at the St John's Institute of Dermatology, Guy's Hospital; Reader in Cutaneous Oncology and Principal Investigator at King's College London. Magnus specialises in the management of complex skin cancers and brings together clinical care, laboratory science and direct access to patients who need this therapy the most.
Senior biomedical scientist and expert in skin-cancer pathology, Jey undertook his PhD in the Lynch lab at King's, where he developed the screening platform that is central to Epistat.
Backed by King's
Epistat Therapeutics is a spinout from King's College London and a member of the 2026 cohort of the King's Spinout Accelerator - a twelve-month programme run by the King's Entrepreneurship Institute that helps researchers turn King's science into companies, with mentoring, commercialisation support and access to the King's Investor Network.
